Summit Therapeutics (SMMT) “announced that Robert LaCaze has joined Summit Therapeutics as Chief Commercial Officer, reporting to Manmeet S.
Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback